Pharmacovigilance news
GVP XVI Review: risk minimization updates
The review introduces important updates relating to risk minimisation measures and their management.
Pharmacovigilance in 2024: how the European landscape is changing
Throughout 2024, the European Medicines Agency (EMA) has spearheaded a series of projects aimed at improving the management of pharmacovigilance data. Here are the main innovations.
EU PhV Congress 2024: an event on pharmacovigilance not to be missed
The European Pharmacovigilance Congress is the unmissable event to discover the latest news on pharmacovigilance, from regulatory challenges to technological developments. Here are the topics of this year.
Rally Lana 2024: 37th edition full of thrills
The Rally Lana 2024 took place on July 19 and 20, attracting drivers and enthusiasts from all over the world to Biella. Once again, SafetyDrugs renewed its role as the official sponsor of this prestigious event.
AIFA launches a new digital platform for the management of pharmacovigilance funds
The management of pharmacovigilance funds will become more efficient thanks to AIFA's new platform.
AFI Symposium 2024: the latest from the pharmaceutical world
Discover the main themes of the AFI Symposium 2024, from sustainability to supply chain challenges, and explore the latest developments.
AFI Symposium 2024: the scientific sessions in the pharmaceutical sector
The AFI Symposium 2024, held from June 5 to 7 in Rimini, offers a significant opportunity for professionals in the pharmaceutical sector to stay updated. Here are the sessions.
Clinical Trials: what are they?
Clinical trials are a fundamental phase in the development of a therapy. We have gathered essential information worth knowing about them.
Pharmacovigilance: Answers to the Frequently Asked Questions about Drug Safety
In a constant effort to promote awareness of the importance of this practice, we have collected and answered the most common questions relating to pharmacovigilance.
Pharmacovigilance: new funds expected from AIFA’s Board of Directors
The new AIFA Board of Directors recently announced the allocation of funds for pharmacovigilance and cybersecurity.
History of pharmacovigilance: evolution and progress in drug safety surveillance
There are numerous events that led to the birth of pharmacovigilance. Here is its evolution from its origins to today.
AIFA reform: what is it and who are the new members of the governance
AIFA has recently embarked on a process of restructuring governance to promote investments in research and development and accelerate drug approval processes.
Pharmacovigilance ICSR management: 10 benefits of the safety database
The safety database is a fundamental tool for efficient pharmacovigilance ICSR management. Here are the main advantages of using it.
ICSR transfer outside of EU: how to comply with the GDPR with SafetyDrugs
The ICSR transfer outside of EU entails risks in terms of compatibility between pharmacovigilance agreements and GDPR. Here's how be compliant.
Signal Management: the process phases
Signal Management is the process of managing safety signals in pharmacovigilance. Here's what phases it consists of and how it is performed.
Signal Validation: what is it and how to perform it
Signal Validation is the activity of verifying the reliability and completeness of the information supporting a potential signal. Here's how it's done according to GVP.
Signal Detection in pharmacovigilance: what it is and how it works
Signal Detection plays a fundamental role in the constant monitoring of the safety profile of a drug. Through this analysis it is possible to promptly identify possible signals of adverse effects associated with the use of a drug. Here's what Signal Detection is and how it's done.
How to choose a safety database: the guide
Here are the best features to look for understand how to choose a safety database